HEMO 2025 / III Simpósio Brasileiro de Citometria de Fluxo
Mais dadosSézary Syndrome (SS) is defined by the triad of erythroderma, generalized lymphadenopathy, and the presence of clonal T cells with cerebriform nuclei (Sézary cells) in peripheral blood. In addition, one or more of the following criteria are required: an absolute Sézary cell count ≥ 1000/μL, an expanded CD4+ T-cell population resulting in a CD4:CD8 ratio of ≥ 10, and loss of one or more T cell antigens. T cells have a CD3+, CD4+, CD8(-) phenotype, and characteristically lack CD7 and CD26. The normal counterparts of Sézary cells are circulating central memory T cells (CD27+, CD45RA(-), CD45RO+). According to the degree of circulating involvement, Staging B (“blood”) for Sézary syndrome follow these criteria: B0: circulating Sezary cells (Fig. 2A) below 250 cells/mm3 or < 5% atypical lymphoid cells in the smear; B1: circulating Sezary cells < 1000 cells/mm3 or 5-20% atypical cells in the smear; B2: circulating Sezary cells above 1000 cells/mm3 or > 20% atypical lymphoid cells in the smear.
ReportMale patient, 88 years old, previous diagnosis of Mycosis fungoides, Peripheral blood sample with white blood count 18,000 cells, 25%TCD4+ and 9.3% Double-Positive Alfa/Beta populations with dim expression of TCD3. Flow Cytometry: 41.5% T Cells: *25% TCD4+ CD3dim CD7+/++ CD27+ CD45RA(-) TCRCBeta1(-)100% (monoclonal); *9.3% Double-negative TCRAlfa/Beta+ CD3dim CD7+ CD27+ CD45RA(-); TCRCBeta1(-)100% (monoclonal); *3% TCD4+ TCRCBeta1+ 36.5% (polyclonal); *3.9% TCD8+ TCRCBeta1+28% (polyclonal). Negative expression: CD8 CD30 CD38 CD45RA CD56 CD57 CD94 TCL1 TCRCBETA1 TCR GAMMA/DELTA.
CommentsThe normal counterparts of Sézary cells are circulating central memory T cells (CD27+, CD45RA(-), CD45RO+); the phenotype profile in our case, with 2 identifiable clones (one TCD4+ clone and one Double-Negative Alfa/Beta clone), matches this description.
Figure 1 Sézary cells in yellow, normal TCD4+ cells in green and normal TCD8+ cells in dark blue.
References
- 1.
Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P. Single antibody detection of T‐cell receptor αβ clonality by flow cytometry rapidly identifies mature T‐cell neoplasms and monotypic small CD8‐positive subsets of uncertain significance. Cytometry B Clin Cytom. 2020;98:99-107.
- 2.
Horna P, Shi M, Jevremovic D, Craig FE, Comfere NI, Olteanu H, et al. Utility of TRBC1 expression in the diagnosis of peripheral blood involvement by cutaneous T-cell lymphoma. J Invest Dermatol. 2021;141:821-9. e2.
- 3.
Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189-99.
- 4.
Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al.; ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-22.
- 5.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720-48.
- 6.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70:205.e1-16; quiz 221-2.
- 7.
Horna P, Shi M, Olteanu H, Johansson U. Emerging role of T-cell receptor constant β chain-1 (TRBC1) expression in the flow cytometric diagnosis of T-cell malignancies. Int J Mol Sci. 2021;22:1817.
